Stroke is a leading cause of morbidity and mortality globally, necessitating prompt recognition and management. This article elucidates the early signs of stroke and provides a comprehensive guide for its management.
Stroke symptoms often appear suddenly and primarily involve neurological deficits. The acronym FAST (Face drooping, Arm weakness, Speech difficulties, and Time to call emergency services) is a quick tool for identification. Other symptoms may include confusion, visual disturbances, dizziness, and severe headache. Early recognition is crucial as it directly affects the prognosis.
Upon suspecting a stroke, healthcare professionals should conduct a rapid assessment using validated tools such as the National Institutes of Health Stroke Scale (NIHSS). This is followed by immediate stabilization of vital signs, securing an airway if needed, and obtaining a non-contrast CT scan to differentiate between ischemic and hemorrhagic stroke.
Ischemic strokes can be managed with intravenous thrombolytics if presented within 4.5 hours of symptom onset. Endovascular thrombectomy is considered for large vessel occlusions. Hemorrhagic strokes require control of blood pressure, reversal of anticoagulation, and neurosurgical consultation. Both types necessitate secondary prevention strategies, including risk factor modification and antithrombotic therapy.
Post-stroke care involves a multidisciplinary team, including physiotherapists, speech and language therapists, and dieticians. This team approach aids in maximizing recovery and minimizing complications.
Early recognition and prompt management of stroke can significantly improve outcomes. Healthcare professionals play a vital role in this process, and their understanding of stroke signs and management strategies is paramount. Continuous education and training in stroke care are imperative to ensure the highest quality of care for these patients.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation